James Buchanan
James Buchanan
Senior Researcher, University of Oxford
Verified email at dph.ox.ac.uk - Homepage
Cited by
Cited by
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
K Schwarze, J Buchanan, JC Taylor, S Wordsworth
Genetics in Medicine 20 (10), 1122-1130, 2018
The challenge of antimicrobial resistance: what economics can contribute
LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ...
Science 364 (6435), 2019
Issues surrounding the health economic evaluation of genomic technologies
J Buchanan, S Wordsworth, A Schuh
Pharmacogenomics 14 (15), 1833-1847, 2013
Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective?
S Wordsworth, J Buchanan, J Mollison, K Harrild, L Robertson, C Tay, ...
Human reproduction 26 (2), 369-375, 2011
Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers
J Buchanan, S Wordsworth, T Ahmad, A Perrin, S Vermeire, M Sans, ...
Journal of Crohn's and Colitis 5 (4), 301-316, 2011
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
K Schwarze, J Buchanan, JM Fermont, H Dreau, MW Tilley, JM Taylor, ...
Genetics in Medicine 22 (1), 85-94, 2020
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom
S Wordsworth, J Buchanan, R Regan, V Davison, K Smith, S Dyer, ...
Genomic medicine 1 (1-2), 35-45, 2007
Women’s birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature
J Hollowell, Y Li, R Malouf, J Buchanan
BMC pregnancy and childbirth 16 (1), 1-17, 2016
Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions
KA Phillips, PA Deverka, DA Marshall, S Wordsworth, DA Regier, ...
Value in Health 21 (9), 1033-1042, 2018
Patients’ Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment
J Buchanan, S Wordsworth, A Schuh
The Patient-Patient-Centered Outcomes Research 9 (6), 525-536, 2016
Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study.
L Pankhurst, L Macfarlane-Smith, J Buchanan, L Anson, K Davies, ...
Health technology assessment (Winchester, England) 18 (53), 1, 2014
Valuation of health and nonhealth outcomes from next-generation sequencing: Approaches, challenges, and solutions
DA Regier, D Weymann, J Buchanan, DA Marshall, S Wordsworth
Value in Health 21 (9), 1043-1047, 2018
Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?
J Buchanan, S Wordsworth
PharmacoEconomics 33 (6), 571-9, 2015
Using “big data” in the cost-effectiveness analysis of next-generation sequencing technologies: challenges and potential solutions
S Wordsworth, B Doble, K Payne, J Buchanan, DA Marshall, C McCabe, ...
Value in Health 21 (9), 1048-1053, 2018
Urgent improvements needed to diagnose and manage Lynch syndrome.
KJ Monahan, D Alsina, S Bach, J Buchanan, J Burn, S Clark, P Dawson, ...
BMJ (Clinical research ed.) 356, j1388-j1388, 2017
The impact of hospital costing methods on cost-effectiveness analysis: a case study
J Leal, S Manetti, J Buchanan
PharmacoEconomics 36 (10), 1263-1272, 2018
Surgery versus surveillance in ulcerative colitis patients with endoscopically invisible low-grade dysplasia: a cost-effectiveness analysis
B Parker, J Buchanan, S Wordsworth, S Keshav, B George, JE East
Gastrointestinal Endoscopy 86 (6), 1088-1099. e5, 2017
Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness
J Buchanan, B Mihaylova, A Gray, N White
PloS one 5 (12), e14446, 2010
Use of decision modelling in economic evaluations of diagnostic tests: an appraisal and review of health technology assessments in the UK
Y Yang, L Abel, J Buchanan, T Fanshawe, B Shinkins
PharmacoEconomics-open 3 (3), 281-291, 2019
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine
P Fahr, J Buchanan, S Wordsworth
Applied health economics and health policy, 1-10, 2019
The system can't perform the operation now. Try again later.
Articles 1–20